AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.120

0.000

Volume:1.21K

Turnover:140.00

Market Cap:44.17M

PE:-5.96

High:0.120

Open:0.115

Low:0.115

Close:0.120

52wk High:0.155

52wk Low:0.052

Shares:368.07M

Float Shares:202.44M

Volume Ratio:0.01

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-97.79%

ROA:-39.67%

PB:7.10

PE(LYR):-5.96

Loading ...

Overview Company News Filings

Citigroup Adjusts Becton, Dickinson and Company PT to $198 From $232, Maintains Buy Rating

MT Newswires Live

Becton, Dickinson Launches $1.6 Billion Tender Offers; Shares Rise

MT Newswires Live

Becton, Dickinson to See 'Transition Year' in 2026 as it Navigates Headwinds, RBC Says

MT Newswires Live

Citigroup Adjusts PT on Becton, Dickinson and Co. to $232 From $233, Maintains Buy Rating

MT Newswires Live

GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.35 - $12.65

MT Newswires Live

Citigroup Resumes Becton, Dickinson at Buy With $233 Price Target

MT Newswires Live

Piper Sandler Adjusts Becton, Dickinson and Company PT to $205 From $190, Maintains Neutral Rating

MT Newswires Live

Becton, Dickinson Announces Quarterly Dividend; Board Approves 10 Million Additional Share Repurchases

MT Newswires Live

Waters Shareholders Approve Merger Deal with Becton, Dickinson's Unit

MT Newswires Live

BCAL Diagnostics Ltd-Mr Mark Mcconnell Appointed to the Board

THOMSON REUTERS

Becton, Dickinson Launches AI Research Tool for Immunology, Cancer Studies

MT Newswires Live

BD to Invest $110 Million for Production of BD Neopak Glass Prefillable Syringe

MT Newswires Live

Is BD (BDX) Quietly Recasting Its Surgical Innovation Story With Expanded Phasix Mesh Use in Europe?

Simply Wall St.

A Look At Becton Dickinson (BDX) Valuation After Phasix Mesh Wins CE Marking In Europe

Simply Wall St.

Becton Dickinson (BDX): Revisiting Valuation After Recent Share Price Rebound

Simply Wall St.

Becton, Dickinson, University of Pennsylvania to Collaborate on Immune Profiling

MT Newswires Live

RBC Adjusts Price Target on Becton, Dickinson to $210 From $202, Maintains Sector Perform Rating

MT Newswires Live

BUZZ-BCAL Diagnostics hits 9-month high on ethics approval in Australia

Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $210 From $197, Maintains Overweight Rating

MT Newswires Live

Becton Dickinson (BDX): Evaluating Valuation After European Launch of Surgiphor and Recent Strategic Moves

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BDX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.12,"timestamp":1770959520000,"preClose":0.12,"halted":0,"volume":1212,"delay":0,"changeRate":0,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":368067640,"eps":-0.020136,"marketStatus":"Market Closed","change":0,"latestTime":"02-13 16:12:00 AEDT","open":0.115,"high":0.12,"low":0.115,"amount":140,"amplitude":0.041667,"askPrice":0.12,"askSize":73929,"bidPrice":0.115,"bidSize":206223,"shortable":3,"etf":0,"ttmEps":-0.020136,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771196400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.12,"openAndCloseTimeList":[[1770937200000,1770958800000]],"volumeRatio":0.014439607414238024,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-39.67%","roe":"-97.79%","lyrEps":-0.020136,"volumeRatio":0.014439607414238024,"shares":368067640,"dividePrice":0,"high":0.12,"amplitude":0.041667,"preClose":0.12,"low":0.115,"week52Low":0.052,"pbRate":"7.10","psRate":"16.67","week52High":0.155,"institutionHeld":0,"latestPrice":0.12,"committee":0.472222,"eps":-0.020136,"divideRate":0,"volume":1212,"delay":0,"ttmEps":-0.020136,"open":0.115,"prevYearClose":0.105,"prevWeekClose":0.117,"prevMonthClose":0.12,"prevQuarterClose":0.105,"fiveDayClose":0.117,"twentyDayClose":0.13,"sixtyDayClose":0.087},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610959444","title":"Citigroup Adjusts Becton, Dickinson and Company PT to $198 From $232, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2610959444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610959444?lang=en_us&edition=fundamental","pubTime":"2026-02-11 23:13","pubTimestamp":1770822785,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $109.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","LU0511384066.AUD","LU0072461881.USD","LU0985489474.SGD","BK4504","LU0006061336.USD","LU1571399168.USD","LU1489326972.SGD","LU1150488135.SGD","LU0130103400.USD","LU0130518102.USD","LU1894683264.USD","LU0162691827.USD","LU0289739343.SGD","LU0433182093.SGD","LU1150488218.USD","LU1059921491.USD","LU0289961442.SGD","LU1854103824.USD","LU0477156797.USD","BDX","LU1894683348.USD","BK4082","LU0648000940.SGD","BDX.AU","BK4585","LU0068578508.USD","LU0985320562.USD","LU1854104046.USD","LU1201861165.SGD","LU0266013472.USD","LU0878866978.SGD","BK7067","BK4588"],"gpt_icon":0},{"id":"2610605678","title":"Becton, Dickinson Launches $1.6 Billion Tender Offers; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605678","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610605678?lang=en_us&edition=fundamental","pubTime":"2026-02-11 02:47","pubTimestamp":1770749220,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Tuesday it launched cash tender offers to buy back up to $1.6 billion of its outstanding debt.The offers cover multiple series of senior notes and debentures, including 6.700% senior notes due 2026; 7.000% senior debentures due 2027; 6.700% senior debentures due 2028; 6.000% senior notes due 2039; 4.875% senior notes due 2044; 4.669% senior notes due 2047; 5.000% senior notes due 2040; 4.685% senior notes due 2044; 5.081% senior notes due 2029; 3.794% senior notes due 2050; 4.874% senior notes due 2029; 4.693% senior notes due 2028; 3.700% senior notes due 2027; 5.110% senior notes due 2034; and 4.298% senior notes due 2032.The tender offers are set to expire at 5 p.m. ET on March 11, with an early tender deadline of Feb. 24, the company said.Shares of Becton, Dickinson rose 5.2% in recent trading.Price: 171.46, Change: +8.48, Percent Change: +5.20","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0266013472.USD","LU0985489474.SGD","LU0130103400.USD","LU0477156797.USD","LU1894683264.USD","LU0162691827.USD","LU0511384066.AUD","LU1854103824.USD","LU0289961442.SGD","LU0006061336.USD","LU0878866978.SGD","BK4588","LU0433182093.SGD","BK4082","LU1571399168.USD","LU1201861165.SGD","LU1150488135.SGD","BK4585","IE00BFXG1179.USD","LU0068578508.USD","LU0648000940.SGD","LU0072461881.USD","LU1854104046.USD","BK4504","LU1894683348.USD","BDX.AU","LU0985320562.USD","BK7067","LU0289739343.SGD","LU0130518102.USD","LU1059921491.USD","LU1150488218.USD","LU1489326972.SGD","BDX"],"gpt_icon":0},{"id":"2610624064","title":"Becton, Dickinson to See 'Transition Year' in 2026 as it Navigates Headwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2610624064","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610624064?lang=en_us&edition=fundamental","pubTime":"2026-02-11 00:16","pubTimestamp":1770740162,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  is facing a \"transition year\" in 2026 as it navigates business headwinds related to China, vaccines, and its Alaris product, starting with a fiscal Q1 beat, RBC Capital Markets said in a Monday note.The company reported fiscal Q1 adjusted earnings of $2.91 per diluted share, down from $3.43 a year earlier, while $5.25 billion increased to $5.17 billion. The company revised its fiscal 2026 adjusted earnings per share outlook to reflect the separation of its Lifesciences business, but reiterated its revenue guidance for the year.RBC said the fiscal 2026 revenue guidance was maintained as \"business trends are playing out as expected, including headwinds.\" The Lifesciences business separation is expected to increase Becton, Dickinson's strategic focus on high-growth markets, the investment firm added.RBC lowered its price target on Becton, Dickinson to $172 from $210, with a sector perform rating.Price: 170.14, Change: +7.16, Percent Change: +4.39","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX.AU","LU0433182093.SGD","LU0985320562.USD","LU0130518102.USD","BDX","LU0130103400.USD","BK4504","LU1201861165.SGD","LU1489326972.SGD","LU0068578508.USD","LU1894683264.USD","LU0072461881.USD","BK4585","LU1150488135.SGD","LU1150488218.USD","LU0289961442.SGD","LU1854104046.USD","LU1854103824.USD","BK4588","LU0006061336.USD","LU0266013472.USD","LU1571399168.USD","LU0985489474.SGD","IE00BFXG1179.USD","LU0162691827.USD","LU1059921491.USD","LU0289739343.SGD","BK4082","LU1894683348.USD","BK7067","LU0648000940.SGD","LU0477156797.USD","LU0511384066.AUD","LU0878866978.SGD"],"gpt_icon":0},{"id":"2610443646","title":"Citigroup Adjusts PT on Becton, Dickinson and Co. to $232 From $233, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2610443646","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610443646?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:47","pubTimestamp":1770720424,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Co. (BDX) has an average rating of overweight and mean price target of $196.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resear","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0433182093.SGD","LU1150488218.USD","LU0878866978.SGD","LU0068578508.USD","BK7067","LU1894683264.USD","BK4504","LU1150488135.SGD","LU0477156797.USD","LU0289961442.SGD","LU0511384066.AUD","LU0648000940.SGD","LU1201861165.SGD","LU1894683348.USD","LU0162691827.USD","BK4585","LU0130103400.USD","BK4588","LU1059921491.USD","LU0006061336.USD","LU0985489474.SGD","BDX","LU0985320562.USD","LU0266013472.USD","IE00BFXG1179.USD","LU1489326972.SGD","BK4082","LU1854103824.USD","LU0130518102.USD","LU1854104046.USD","LU0072461881.USD","BDX.AU","LU0289739343.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2610632645","title":"GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.35 - $12.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2610632645","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610632645?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:43","pubTimestamp":1770637400,"startTime":"0","endTime":"0","summary":"GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.35 - $12.65","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX.AU","BDX"],"gpt_icon":0},{"id":"2608282726","title":"Citigroup Resumes Becton, Dickinson at Buy With $233 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2608282726","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608282726?lang=en_us&edition=fundamental","pubTime":"2026-02-03 19:02","pubTimestamp":1770116577,"startTime":"0","endTime":"0","summary":"Becton, Dickinson & Co. (BDX) has an average rating of overweight and mean price target of $205.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX.AU","LU0433182093.SGD","LU0985320562.USD","LU0130518102.USD","BDX","LU0130103400.USD","BK4504","LU1201861165.SGD","LU1489326972.SGD","LU0068578508.USD","LU1894683264.USD","LU0072461881.USD","BK4585","LU1150488135.SGD","LU1150488218.USD","LU0289961442.SGD","LU1854104046.USD","LU1854103824.USD","BK4588","LU0006061336.USD","LU0266013472.USD","LU1571399168.USD","LU0985489474.SGD","IE00BFXG1179.USD","LU0162691827.USD","LU1059921491.USD","LU0289739343.SGD","BK4082","LU1894683348.USD","BK7067","LU0648000940.SGD","LU0477156797.USD","LU0511384066.AUD","LU0878866978.SGD"],"gpt_icon":0},{"id":"2606568748","title":"Piper Sandler Adjusts Becton, Dickinson and Company PT to $205 From $190, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2606568748","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606568748?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:59","pubTimestamp":1769612341,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $202.11, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1489326972.SGD","LU1059921491.USD","BDX","LU1150488135.SGD","BK7067","LU0289961442.SGD","LU1894683264.USD","LU0648000940.SGD","BK4588","LU0511384066.AUD","LU1150488218.USD","LU1571399168.USD","LU1854103824.USD","LU0878866978.SGD","BK4504","IE00BFXG1179.USD","LU0068578508.USD","BDX.AU","LU0130103400.USD","LU1201861165.SGD","LU0130518102.USD","LU0985320562.USD","LU0985489474.SGD","LU0266013472.USD","BK4585","LU0072461881.USD","BK4082","LU0162691827.USD","LU0433182093.SGD","LU0289739343.SGD","LU1894683348.USD","LU0477156797.USD","LU0006061336.USD","LU1854104046.USD"],"gpt_icon":0},{"id":"2606753971","title":"Becton, Dickinson Announces Quarterly Dividend; Board Approves 10 Million Additional Share Repurchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2606753971","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606753971?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:39","pubTimestamp":1769549945,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company  said late Tuesday it has kept its quarterly dividend at $1.05 per share, payable March 31 to shareholders of record as of March 12.The annual dividend is $4.20 per share.The company said it repurchased $250 million in stock to date during fiscal 2026.The board has authorized the company to repurchase up to 10 million common shares in addition to the shares that remain available under the prior authorizations in 2021 and 2025, the company added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0266013472.USD","LU0985489474.SGD","LU0130103400.USD","LU0477156797.USD","LU1894683264.USD","LU0162691827.USD","LU0511384066.AUD","LU1854103824.USD","LU0289961442.SGD","LU0006061336.USD","LU0878866978.SGD","BK4588","LU0433182093.SGD","BK4082","LU1571399168.USD","LU1201861165.SGD","LU1150488135.SGD","BK4585","IE00BFXG1179.USD","LU0068578508.USD","LU0648000940.SGD","LU0072461881.USD","LU1854104046.USD","BK4504","LU1894683348.USD","BDX.AU","LU0985320562.USD","BK7067","LU0289739343.SGD","LU0130518102.USD","LU1059921491.USD","LU1150488218.USD","LU1489326972.SGD","BDX"],"gpt_icon":1},{"id":"2606735585","title":"Waters Shareholders Approve Merger Deal with Becton, Dickinson's Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2606735585","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606735585?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:33","pubTimestamp":1769528000,"startTime":"0","endTime":"0","summary":"Waters  said Tuesday its shareholders have approved the planned merger deal with Becton, Dickinson and Company's  Biosciences & Diagnostic Solutions business.The firm said its stockholders approved the issuance of shares to shareholders of Becton, Dickinson and Company at a special meeting. The transaction is expected to close on Feb. 9.Price: 388.97, Change: -1.94, Percent Change: -0.50","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2413666699.HKD","LU0289961442.SGD","LU0347712357.USD","LU1150488135.SGD","LU0072461881.USD","LU0433182093.SGD","LU0511384066.AUD","LU2404859667.USD","LU0266013472.USD","LU1894683264.USD","LU0690374615.EUR","WAT.AU","BK4082","LU1721428933.USD","BK7118","GB00B4LPDJ14.GBP","LU1489326972.SGD","LU2413666426.HKD","LU1571399168.USD","LU0162691827.USD","LU0690374961.EUR","LU1894683348.USD","LU0648000940.SGD","LU1059921491.USD","LU1854103824.USD","WAT","LU0068578508.USD","GB00B4QBRK32.GBP","BK7067","LU1201861165.SGD","LU0985320562.USD","LU0289739343.SGD","IE00BFXG1179.USD","BK4588","LU0878866978.SGD","LU0006061336.USD","LU0477156797.USD","BK4504","BK4121","LU0985489474.SGD","LU2404859741.USD","LU1854104046.USD","LU1150488218.USD","BDX.AU","BDX","LU0130518102.USD","BK4585","LU0130103400.USD"],"gpt_icon":0},{"id":"2606229411","title":"BCAL Diagnostics Ltd-Mr Mark Mcconnell Appointed to the Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2606229411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606229411?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:51","pubTimestamp":1769464316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nTUE7TXHHR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BDX.AU"],"gpt_icon":0},{"id":"2605477798","title":"Becton, Dickinson Launches AI Research Tool for Immunology, Cancer Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605477798","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605477798?lang=en_us&edition=fundamental","pubTime":"2026-01-23 20:38","pubTimestamp":1769171903,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company  said Friday it released an updated cloud platform featuring an artificial intelligence tool to automate experimental panel design for cancer research.The system uses a specific algorithm to provide design suggestions for researchers to help ensure study results are reliable, the company said.The software also assists with team cooperation and tracks laboratory duties like buying supplies or checking equipment health, BD said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","LU0477156797.USD","BK7067","LU0068578508.USD","BK4585","LU0006061336.USD","LU1150488135.SGD","BK4588","LU1059921491.USD","LU1150488218.USD","LU1894683348.USD","LU0511384066.AUD","LU0130518102.USD","LU0162691827.USD","LU0289961442.SGD","BDX","LU1854103824.USD","LU1854104046.USD","LU0433182093.SGD","LU0266013472.USD","LU1201861165.SGD","LU1894683264.USD","LU0985489474.SGD","LU0072461881.USD","BDX.AU","LU0130103400.USD","LU0648000940.SGD","LU1571399168.USD","LU0878866978.SGD","LU0985320562.USD","BK4504","LU0289739343.SGD","BK4082","LU1489326972.SGD"],"gpt_icon":0},{"id":"2603689236","title":"BD to Invest $110 Million for Production of BD Neopak Glass Prefillable Syringe","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689236","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689236?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:34","pubTimestamp":1768307648,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company  said Tuesday it will invest $110 million to establish BD Neopak glass prefillable syringe production at its site in Columbus, Nebraska, with supply expected to begin in mid-2026.BD Neopak glass prefillable syringe production will be available in 1 mL and 2.25 mL formats, the company said.A part of the investment will go toward additional line upgrades and capacity improvements at the facility.BD will also invest $10 million to improve cannula manufacturing capabilities at the site.BD said these investments are expected to create around 120 new jobs.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","LU0289961442.SGD","LU0878866978.SGD","LU0130103400.USD","LU0985320562.USD","LU1201861165.SGD","LU0985489474.SGD","LU0072461881.USD","LU1059921491.USD","BDX.AU","LU0068578508.USD","LU0433182093.SGD","BK4585","LU0289739343.SGD","LU1894683264.USD","BK4082","LU0162691827.USD","LU0648000940.SGD","LU1854103824.USD","LU0006061336.USD","LU1894683348.USD","LU0511384066.AUD","LU0266013472.USD","BK7067","BDX","LU1150488218.USD","LU1150488135.SGD","LU0130518102.USD","LU0477156797.USD","LU1489326972.SGD","BK4504","LU1571399168.USD","LU1854104046.USD","BK4588"],"gpt_icon":0},{"id":"2602316084","title":"Is BD (BDX) Quietly Recasting Its Surgical Innovation Story With Expanded Phasix Mesh Use in Europe?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602316084","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602316084?lang=en_us&edition=fundamental","pubTime":"2026-01-09 06:33","pubTimestamp":1767911584,"startTime":"0","endTime":"0","summary":"In recent days, BD (Becton, Dickinson and Company) reported the first European prophylactic laparotomy reinforcement case in Greece using its Phasix™ Mesh, following expanded CE-marked approval, new product sizes, and broader availability across Europe and the U.K. for hernia prophylaxis indications.\nThis broader European indication, supported by ongoing PREVENT trial enrollment, points to a potentially wider clinical role for bioabsorbable mesh in high‑risk abdominal surgeries and...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-bd-bdx-quietly-recasting-its-surgical-innovation-story-wi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-bd-bdx-quietly-recasting-its-surgical-innovation-story-wi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BFXG1179.USD","LU1059921491.USD","LU1854104046.USD","BDX","BK4585","BK4504","LU0006061336.USD","LU0433182093.SGD","LU1894683264.USD","LU0289739343.SGD","LU0289961442.SGD","LU0130518102.USD","LU0068578508.USD","LU1854103824.USD","BK7067","BK4082","LU1201861165.SGD","LU0985320562.USD","LU1571399168.USD","LU0477156797.USD","LU0072461881.USD","LU0266013472.USD","LU0162691827.USD","LU0130103400.USD","LU0648000940.SGD","LU1150488135.SGD","LU1489326972.SGD","LU0511384066.AUD","LU0985489474.SGD","LU0878866978.SGD","LU1894683348.USD","BK4588","BDX.AU","LU1150488218.USD"],"gpt_icon":0},{"id":"2601787523","title":"A Look At Becton Dickinson (BDX) Valuation After Phasix Mesh Wins CE Marking In Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2601787523","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601787523?lang=en_us&edition=fundamental","pubTime":"2026-01-07 14:29","pubTimestamp":1767767358,"startTime":"0","endTime":"0","summary":"Becton Dickinson (BDX) is in focus after its Phasix Mesh received CE marking for prophylactic hernia use across Europe and was used in a first laparotomy reinforcement case in Greece, widening its surgical reach.\nSee our latest analysis for Becton Dickinson.\nThe Phasix Mesh news comes as Becton Dickinson’s share price has shown recent momentum, with a 7 day share price return of 4.97% and a 30 day share price return of 5.88%. However, the 1 year total shareholder return of a 9.63% decline and...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/a-look-at-becton-dickinson-bdx-valuation-after-phasix-mesh-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/a-look-at-becton-dickinson-bdx-valuation-after-phasix-mesh-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0477156797.USD","DCF","BDX.AU","BK4082","LU0006061336.USD","BK4504","LU1150488218.USD","BK4109","LU1894683264.USD","LU0068578508.USD","LU1571399168.USD","LU0130518102.USD","LU0511384066.AUD","LU0878866978.SGD","CE","BK7067","LU0985489474.SGD","LU1059921491.USD","LU1201861165.SGD","LU0289961442.SGD","BK4588","LU0162691827.USD","IE00BFXG1179.USD","LU1854103824.USD","LU0648000940.SGD","LU0072461881.USD","LU1150488135.SGD","LU0266013472.USD","LU1489326972.SGD","BK4585","LU1894683348.USD","LU0130103400.USD","LU1854104046.USD","BDX","LU0289739343.SGD","LU0985320562.USD","LU0433182093.SGD"],"gpt_icon":0},{"id":"2593212442","title":"Becton Dickinson (BDX): Revisiting Valuation After Recent Share Price Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2593212442","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593212442?lang=en_us&edition=fundamental","pubTime":"2025-12-21 17:12","pubTimestamp":1766308370,"startTime":"0","endTime":"0","summary":"Becton Dickinson (BDX) has quietly outperformed the broader healthcare space over the past 3 months, even as its share price is still down year to date, which creates an interesting setup for long term investors.\nSee our latest analysis for Becton Dickinson.\nWith the share price now around $195.59, Becton Dickinson’s 90 day share price return of 4.85% contrasts with a weak year to date share price return of minus 13.64%. Its five year total shareholder return of minus 12.32% shows that...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-revisiting-valuation-after-recent-share","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-revisiting-valuation-after-recent-share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0477156797.USD","BDX.AU","LU0289739343.SGD","LU0878866978.SGD","LU1854104046.USD","LU0130518102.USD","LU0072461881.USD","LU1150488218.USD","IE00BFXG1179.USD","LU1894683264.USD","LU1571399168.USD","LU0006061336.USD","BK4504","LU0266013472.USD","LU0985320562.USD","LU0162691827.USD","LU0068578508.USD","BK4585","LU0511384066.AUD","LU0648000940.SGD","LU1894683348.USD","LU0433182093.SGD","LU1059921491.USD","LU0289961442.SGD","LU1150488135.SGD","LU1489326972.SGD","LU1201861165.SGD","BK4588","LU0985489474.SGD","BK4082","BDX","LU0130103400.USD","LU1854103824.USD","BK7067"],"gpt_icon":0},{"id":"2592905918","title":"Becton, Dickinson, University of Pennsylvania to Collaborate on Immune Profiling","url":"https://stock-news.laohu8.com/highlight/detail?id=2592905918","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592905918?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:44","pubTimestamp":1766061882,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Thursday that it agreed to collaborate with the University of Pennsylvania's Institute for Immunology and Immune Health on deep human immune profiling research and the development of immune-mediated therapies.The collaboration includes the development of a high-parameter flow cytometry panel that can provide insight into how single cells respond to drugs or disease states, the company said. This panel is expected to support a planned 1,000-patient immune profiling study that is set to start in summer, Becton, Dickinson added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0648000940.SGD","LU1201861165.SGD","LU0289739343.SGD","LU1150488135.SGD","LU1571399168.USD","LU0878866978.SGD","LU0985489474.SGD","LU0006061336.USD","BDX.AU","LU1150488218.USD","LU0130103400.USD","LU0477156797.USD","LU1854103824.USD","LU0162691827.USD","LU0072461881.USD","IE00BFXG1179.USD","BK4588","LU0266013472.USD","BK7067","LU1854104046.USD","LU1894683264.USD","LU1489326972.SGD","BK4585","LU0985320562.USD","BDX","LU1894683348.USD","LU0433182093.SGD","BK4504","BK4082","LU0289961442.SGD","LU0130518102.USD","LU0068578508.USD","LU1059921491.USD","LU0511384066.AUD"],"gpt_icon":0},{"id":"2592194779","title":"RBC Adjusts Price Target on Becton, Dickinson to $210 From $202, Maintains Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2592194779","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592194779?lang=en_us&edition=fundamental","pubTime":"2025-12-17 23:25","pubTimestamp":1765985114,"startTime":"0","endTime":"0","summary":"Becton, Dickinson (BDX) has an average rating of overweight and mean price target of $198.56, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1150488218.USD","BDX","LU1059921491.USD","LU0648000940.SGD","LU0477156797.USD","LU0130518102.USD","LU0511384066.AUD","LU1854103824.USD","LU1571399168.USD","LU0162691827.USD","LU0006061336.USD","LU0985489474.SGD","LU0985320562.USD","BK4504","LU1894683348.USD","LU1489326972.SGD","LU1201861165.SGD","LU0433182093.SGD","LU1854104046.USD","LU0289739343.SGD","IE00BFXG1179.USD","LU0289961442.SGD","BK4585","BK7067","BK4082","LU0068578508.USD","BK4588","LU0878866978.SGD","BDX.AU","LU0266013472.USD","LU0130103400.USD","LU1150488135.SGD","LU1894683264.USD","LU0072461881.USD"],"gpt_icon":0},{"id":"2588096887","title":"BUZZ-BCAL Diagnostics hits 9-month high on ethics approval in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2588096887","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588096887?lang=en_us&edition=fundamental","pubTime":"2025-12-03 10:33","pubTimestamp":1764729235,"startTime":"0","endTime":"0","summary":"BUZZ-BCAL Diagnostics hits 9-month high on ethics approval in Australia** BCAL Diagnostics BDX.AX jumps as much as 9.1% to A$0.12, highest since February 24** Diagnostics firm gets national ethics approval in Australia for a registry study on up to 24,000 women where subjects will use co's breast cancer screening product BREASTESTplus as part of their clinical treatment** CEO says registry will accelerate doctor adoption while collecting real-world data to support future reimbursement** YTD, BDX gains 13.4%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nL6N3X905R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BDX.AU"],"gpt_icon":0},{"id":"2588030493","title":"Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $210 From $197, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2588030493","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588030493?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:07","pubTimestamp":1764677234,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $197.11, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1894683264.USD","LU0130103400.USD","LU0068578508.USD","LU0289961442.SGD","BDX.AU","IE00BFXG1179.USD","LU1201861165.SGD","LU1894683348.USD","LU1854104046.USD","LU0985489474.SGD","LU1571399168.USD","LU0289739343.SGD","LU1059921491.USD","BK7067","LU0162691827.USD","BDX","LU1150488135.SGD","BK4082","LU0266013472.USD","BK4585","LU0511384066.AUD","LU0477156797.USD","LU0648000940.SGD","LU0130518102.USD","LU0006061336.USD","LU0985320562.USD","LU1150488218.USD","BK4588","LU0878866978.SGD","BK4504","LU0072461881.USD","LU0433182093.SGD","LU1854103824.USD","LU1489326972.SGD"],"gpt_icon":0},{"id":"2587475669","title":"Becton Dickinson (BDX): Evaluating Valuation After European Launch of Surgiphor and Recent Strategic Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2587475669","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587475669?lang=en_us&edition=fundamental","pubTime":"2025-11-29 07:30","pubTimestamp":1764372612,"startTime":"0","endTime":"0","summary":"Becton Dickinson (BDX) unveiled its BD Surgiphor Surgical Wound Irrigation System across select European countries following CE approval for the product. This marks a notable addition to its infection control and surgical offerings.\nSee our latest analysis for Becton Dickinson.\nThe Surgiphor launch is not happening in isolation. BD has also been investing in growth drivers such as the recent acquisition of Edwards Lifesciences’ Critical Care group and a board refresh, signaling a focus on...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-evaluating-valuation-after-european-lau","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-evaluating-valuation-after-european-lau","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0130103400.USD","LU0511384066.AUD","BK7067","LU0985320562.USD","LU0130518102.USD","BK4588","LU1894683264.USD","LU1059921491.USD","LU0068578508.USD","LU1854104046.USD","LU0648000940.SGD","LU0477156797.USD","LU1201861165.SGD","LU0878866978.SGD","LU1150488218.USD","LU1854103824.USD","LU0006061336.USD","IE00BFXG1179.USD","LU0162691827.USD","LU1150488135.SGD","LU0266013472.USD","LU1571399168.USD","BDX","LU0072461881.USD","BK4082","LU0289739343.SGD","LU0985489474.SGD","BDX.AU","LU0433182093.SGD","BK4504","BK4585","LU0289961442.SGD","LU1489326972.SGD","LU1894683348.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}